• 1. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 2. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 3. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 4. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 5. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridines and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives

Comprehensive Analysis of 2-Bromo-7-chloro-[1,3]thiazolo[5,4-c]pyridine (CAS No. 1206248-68-1)

The heterocyclic compound 2-bromo-7-chloro-[1,3]thiazolo[5,4-c]pyridine (CAS 1206248-68-1) has garnered significant attention in pharmaceutical and materials science research due to its unique fused-ring structure. As a thiazolo[5,4-c]pyridine derivative, this molecule serves as a versatile building block in drug discovery, particularly for kinase inhibitors and antimicrobial agents. Recent studies highlight its potential in addressing antibiotic resistance – a critical global health challenge – through novel mechanism-of-action designs.

Structural analysis reveals that the bromo and chloro substituents at positions 2 and 7 respectively enable diverse functionalization pathways. The electron-withdrawing properties of these halogens make the compound particularly valuable for palladium-catalyzed cross-coupling reactions, a topic frequently searched in synthetic chemistry forums. Researchers are actively investigating its application in PET radiotracer development, where the thiazolo[5,4-c]pyridine core shows promising pharmacokinetic properties for neurological imaging.

From a materials perspective, the π-conjugated system of this heterocycle exhibits interesting photophysical properties. Patent literature indicates growing interest in its incorporation into OLED materials and organic semiconductors, addressing the sustainable electronics trend. The compound's stability under physiological conditions makes it particularly attractive for bioconjugation applications – a technique increasingly important in targeted drug delivery systems.

Quality control protocols for CAS 1206248-68-1 typically involve HPLC-UV analysis with retention time verification against reference standards. Analytical chemists emphasize the importance of monitoring the regioisomeric purity of such fused heterocycles, as even minor impurities can significantly impact biological activity. Recent advancements in continuous flow chemistry have improved the scalability of its synthesis while reducing environmental impact – a key consideration in modern green chemistry initiatives.

The scientific community continues to explore structure-activity relationships of 2-bromo-7-chloro-[1,3]thiazolo[5,4-c]pyridine derivatives. Computational chemistry studies utilizing density functional theory (DFT) provide valuable insights into its electronic properties and potential binding modes with biological targets. These investigations align with current interests in AI-driven drug discovery, where such scaffolds serve as valuable inputs for machine learning models predicting novel bioactive compounds.

Storage and handling recommendations for this compound emphasize protection from light and moisture to maintain stability. While not classified as hazardous under standard conditions, proper laboratory practices should always be followed when working with any chemical substance. The growing demand for this intermediate reflects broader trends in fragment-based drug design and medicinal chemistry optimization strategies.

Emerging applications in agrochemical research demonstrate the compound's utility beyond pharmaceuticals. Its structural features show promise in developing new generation crop protection agents with improved environmental profiles. This dual-use potential makes 1206248-68-1 an interesting case study in molecular diversification strategies across different industries.

Recent patent analyses reveal an upward trend in filings incorporating the thiazolo[5,4-c]pyridine scaffold, particularly in combination with biodegradable polymer technologies. This development addresses both the need for novel therapeutic agents and the growing demand for sustainable material solutions – two of the most pressing challenges in contemporary chemical research and development.

• 1849-69-0(2-Bromo-4,5-dichlorobenzothiazole)
• 1188247-19-9(2-Bromo-6,7-dichlorobenzothiazole, 97%)
• 3622-40-0(2-bromo-4-chloro-1,3-benzothiazole)
• 412923-49-0(2-Bromo-4,6-dichlorobenzo[d]thiazole)
• 89642-32-0(2-BROMO-5,6-DICHLOROBENZOTHIAZOLE)
• 2941-56-2(2-bromo-5-chloro-1,3-benzothiazole)
• 3507-58-2(2-Bromo-7-chlorobenzo[d]thiazole)
• 3507-17-3(2-Bromo-6-chlorobenzodthiazole)
• 1849-68-9(2-bromo-4,7-dichloro-1,3-benzothiazole)
• 1206250-69-2(2-Bromothiazolo[5,4-c]pyridine)